VA Criteria for Use Formulary Advisor Reference
← Back to Drug List

ECALLANTIDE INJ

Generic Name
ECALLANTIDE INJ
Brand Names
KALBITOR
Drug Class
IMMUNOLOGICAL AGENTS,OTHER
Formulary Status
Non-Formulary Requires prior authorization
Copay Tier
3
Last Updated
August 1, 2026

Clinical Criteria Summary

Exclusion Criteria

  • Concomitant use with another acute therapy agent for HAE (e.g., icatibant or sebetralstat)

Inclusion Criteria

  • Restricted to VA / VA Community Care allergy/immunology, dermatology, or emergency medicine providers or locally designated expert
  • Suspected bradykinin-mediated angioedema
  • Contraindication, intolerance, or inadequate therapeutic response to either icatibant or C1 inhibitor for acute attack treatment

Source Documents

Download CFU PDF: Ecallantide KALBITOR CFU